India

FDA
Manufacturing

Sun plant placed on FDA import alert over contamination issues

Ongoing issues at Sun Pharma’s production facility in Gujarat, India, have resulted in the FDA putting the facility on import alert status.
Joseph Keenan Sep 11, 2025 9:25am
newspaper

Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia

Sep 5, 2025 9:00am
AZ

AstraZeneca cancels Indian manufacturing license

Sep 3, 2025 12:00pm
newspaper

Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia

Aug 15, 2025 8:31am
illustration of two people putting puzzle pieces together merger and acquisition concept

Torrent Pharma wraps India's JB Pharma into its fold for $1.4B

Jul 1, 2025 11:43am
FDA

India's Aspen Biopharma Labs hit with FDA warning letter

Mar 26, 2025 1:09pm